AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions

Depressive Disorder, Major

Interventions

DRUG

Testosterone gel

AndroGel 2.5g and 5g sachets at doses ranging from 10g/day for duration of trial.

DRUG

Placebo

Trial Locations (2)

The Chaim Sheba Medical Center, Tel Litwinsky

McLean Hospital, Belmont

All Listed Sponsors

collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

Mclean Hospital

OTHER

NCT00304746 - AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment | Biotech Hunter | Biotech Hunter